Sie suchten nach: proteinske (Kroatisch - Englisch)

+ do 2 % za proteinske usjeve
+ up to 2% for protein crops

to nije neobično za proteinske otopine.
this is not unusual for proteinaceous solutions.

ovaj izgled nije neobičan za proteinske otopine.
this appearance is not unusual for proteinaceous solutions.

djelatna tvar lijeka nexavar, sorafenib, je inhibitor proteinske kinaze.
the active substance in nexavar, sorafenib, is a protein kinase inhibitor.

otopina može, u tragovima, sadržavati prozirne do bijele proteinske čestice.
the solution may contain trace amounts of translucent to white proteinaceous particles.

bezbojna otopina koja može sadržavati poluprozirne do bijele, vidljive amorfne proteinske čestice panitumumaba.
colourless solution that may contain, translucent to white, visible amorphous, proteinaceous panitumumab particles.

fab fragment uključuje proteinske dijelove te se može očekivati da će se proteolizom razgraditi u peptide i aminokiseline.
the fab' fragment comprises protein compounds and is expected to be degraded to peptides and amino acids by proteolysis.

bistra, bezbojna do blago žuta otopina koja može sadržavati u tragovima prozirne do bijele proteinske čestice.
clear, colourless to slightly yellow solution and may contain trace amounts of translucent to white proteinaceous particles.

budući da je daratumumab protein, u razrijeđenoj otopini mogu nastati vrlo male, prozirne do bijele proteinske čestice.
the diluted solution may develop very small, translucent to white proteinaceous particles, as daratumumab is a protein.

kao i za druge proteinske lijekove, očekuje se da će se blinatumomab razgraditi u male peptide i aminokiseline kroz kataboličke puteve.
like other protein therapeutics, blinatumomab is expected to be degraded into small peptides and amino acids via catabolic pathways.

u koncentratu mogu biti prisutne proteinske čestice koje izgledaju kao prozirne do bijele amorfne čestice, od kojih neke mogu izgledati vlaknasto.
proteinaceous particles may be present in the concentrate that appear as translucent to white, amorphous particles, some of which may look fibrous.

procjene ex vivo uporabom komercijalnog kompleta za ispitivanje radi kvantifikacije odgovora t- stanica na proteinske terapeutike ukazuju na nizak rizik od imunogenosti.
ex vivo evaluations using a commercial assay kit to quantify t cell response to protein therapeutics indicate a low risk of immunogenicity.

međutim, istraživanja u proteinske usjeve bila su ograničena u usporedbi s drugim sektorima proizvodnje što je prouzročilo zaostajanje u prinosima proteinskih usjeva u posljednjim desetljećima.
nevertheless, research into protein crops has remained limited compared with other production sectors, with the result that protein crop yields have fallen behind in the last decades.

osim toga, postoji mogućnost pružanja dodatnog iznosa (do 2 %) „vezane” potpore za proteinske usjeve.
there is a possibility of providing an additional amount (up to 2%) of "coupled" support for protein crops.

razgradnja idursulfaze uglavnom se postiže dobro poznatim mehanizmima proteinske hidrolize pri kojoj nastaju mali peptidi i aminokiseline, zbog čega se ne očekuje da će oštećenja bubrežne i jetrene funkcije utjecati na farmakokinetiku idursulfaze.
degradation of idursulfase is achieved by generally well understood protein hydrolysis mechanisms to produce small peptides and amino acids, consequently renal and liver function impairment is not expected to affect the pharmacokinetics of idursulfase.

kako se očekuje od heterologne proteinske strukture hormona, lutropin alfa potaknuo je odgovor protutijela u eksperimentalnih životinja nakon razdoblja tijekom kojeg se smanjuju razine mjerljivog serumskog lh, ali nije u potpunosti spriječio njegovu biološku aktivnost.
as expected from the heterologous protein nature of the hormone, lutropin alfa raised an antibody response in experimental animals after a period that reduced the measurable serum lh levels but did not fully prevent its biological action.

tim hrvatskih znanstvenika koje je predvodio miroslav radman izolirao je visoko otporne organizme koji posjeduju male molekule sposobne zaštititi proteine, uključujući "proteinske liječnike" koji obnavljaju oštećenja stanica.
a team of croatian scientists headed by miroslav radman isolated highly resistant organisms that possess small molecules able to protect proteins, including "protein doctors" that repair cell damage.

aflibercept je dimerički glikoprotein proteinske molekularne težine 97 kilodaltona (kda), a sadrži glikozilaciju koja čini dodatnih 15% ukupne molekularne mase, pa ukupna molekularna težina iznosi 115 kda.
aflibercept is a dimeric glycoprotein with a protein molecular weight of 97 kilodaltons (kda) and contains glycosylation, constituting an additional 15% of the total molecular mass, resulting in a total molecular weight of